Tanaka M, Matsuo Y, Yamakage H, Masuda S, Terada Y, Muranaka K, Wada H, Hasegawa K, Shimatsu A, Satoh-Asahara N
In a 24-week semaglutide trial involving men with obesity and type 2 diabetes, participants showed improvements in sperm shape a key measure of sperm quality known as morphology as well as improved cholesterol levels, while testosterone and other hormone levels remained stable
Furthermore, altered white-matter connectivity between the dorsal/medial ACC and posterior cingulate cortex, as well as between the dorsolateral PFC and orbital PFC, has been detected in bipolar disorder patients compared with healthy subjects (132)
Available: [Accessed: 29-Aug-2020]
FDA-approved semaglutide for weight management Wegovy is an FDA-approved brand-name semaglutide specifically indicated for chronic weight management in adults with obesity or overweight